U Leuschner

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi request reprint Primary biliary cirrhosis--presentation and diagnosis
    Ulrich Leuschner
    Johann Wolfgang Goethe University, Medical Clinic II, Theodor Stern Kai 7, Frankfurt am Main, Germany
    Clin Liver Dis 7:741-58. 2003
  2. ncbi request reprint Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis
    U Leuschner
    Medizinische Klinik der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
    Z Gastroenterol 43:1051-9. 2005
  3. ncbi request reprint [Extrahepatic manifestations of liver diseases: skeleton]
    U Leuschner
    Universitatsklinikum Frankfurt
    Praxis (Bern 1994) 95:1550-6. 2006
  4. doi request reprint High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
    Ulrich F H Leuschner
    Interdisziplinäres Facharztzentrum Sachsenhausen, Frankfurt, Germany
    Hepatology 52:472-9. 2010
  5. ncbi request reprint Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid
    Karin Henzel
    Medical Clinic II, Department of Gastroenterology, Center of Internal Medicine, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D 60590 Frankfort on the Main, Germany
    Biochim Biophys Acta 1644:37-45. 2004
  6. ncbi request reprint The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study
    Maria Leuschner
    Medical Clinic II, Johann Wolfgang Goethe Universitat, Frankfurt am Main, Germany
    Eur J Gastroenterol Hepatol 14:1369-76. 2002
  7. ncbi request reprint 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis
    Julia Holtmeier
    Medical Department I, Johann Wolfgang Goethe University of Frankfurt Main, Germany
    Scand J Gastroenterol 41:1336-41. 2006
  8. ncbi request reprint Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture
    Danute Speiciene
    Center of Hepatology, Gastroenterology, and Dietetics of Vilnius University, Vilnius, Lithuania
    Med Sci Monit 13:CR299-306. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Primary biliary cirrhosis--presentation and diagnosis
    Ulrich Leuschner
    Johann Wolfgang Goethe University, Medical Clinic II, Theodor Stern Kai 7, Frankfurt am Main, Germany
    Clin Liver Dis 7:741-58. 2003
    ..Liver histology is of interest for the assessment of the diagnosis and for staging of the disease...
  2. ncbi request reprint Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis
    U Leuschner
    Medizinische Klinik der Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany
    Z Gastroenterol 43:1051-9. 2005
    ....
  3. ncbi request reprint [Extrahepatic manifestations of liver diseases: skeleton]
    U Leuschner
    Universitatsklinikum Frankfurt
    Praxis (Bern 1994) 95:1550-6. 2006
    ..We are still lacking convincing long-term treatment studies with a sufficient number of patients who are well stratified...
  4. doi request reprint High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
    Ulrich F H Leuschner
    Interdisziplinäres Facharztzentrum Sachsenhausen, Frankfurt, Germany
    Hepatology 52:472-9. 2010
    ..133, P for PP = 0.140). With the exception of gamma-glutamyl transferase, UDCA did not improve laboratory data. Conclusion: High-dose UDCA failed to improve the overall histology in patients with NASH in comparison with placebo...
  5. ncbi request reprint Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid
    Karin Henzel
    Medical Clinic II, Department of Gastroenterology, Center of Internal Medicine, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D 60590 Frankfort on the Main, Germany
    Biochim Biophys Acta 1644:37-45. 2004
    ..In contrast, preincubation with bile acids intensified cell damage. Therefore, the protective effect of UDCA or TUDCA in alcohol- or acetaldehyde-treated SK-Hep-1 cells remains dubious...
  6. ncbi request reprint The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study
    Maria Leuschner
    Medical Clinic II, Johann Wolfgang Goethe Universitat, Frankfurt am Main, Germany
    Eur J Gastroenterol Hepatol 14:1369-76. 2002
    ..In these patients we investigated whether the strongly choleretic sulindac together with UDCA is superior to UDCA monotherapy...
  7. ncbi request reprint 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis
    Julia Holtmeier
    Medical Department I, Johann Wolfgang Goethe University of Frankfurt Main, Germany
    Scand J Gastroenterol 41:1336-41. 2006
    ..The aim of this study was to find out whether these breath tests are sensitive parameters also in non-cirrhotic patients with primary biliary cirrhosis...
  8. ncbi request reprint Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture
    Danute Speiciene
    Center of Hepatology, Gastroenterology, and Dietetics of Vilnius University, Vilnius, Lithuania
    Med Sci Monit 13:CR299-306. 2007
    ..The aim was to analyze the clinical, biochemical, immunological, and histological criteria of PBC patients in Lithuania and evaluate the patterns of disease presentation and histological features...